Ca2+/calmodulin-dependent protein kinase II stimulates c-fos transcription and DNA synthesis by a Src-based mechanism in glomerular mesangial cells

被引:28
作者
Wang, Y
Mishra, R
Simonson, MS
机构
[1] Case Western Reserve Univ, Dept Med, Div Nephrol, Sch Med, Cleveland, OH 44106 USA
[2] Univ Hosp Cleveland, Cleveland, OH 44106 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷 / 01期
关键词
D O I
10.1097/01.ASN.0000043180.18456.47
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Mesangial cell growth factors elevate intracellular free [Ca2+](i), but mechanisms linking [Ca2+](i) to gene expression and DNA synthesis are unclear. This study investigated the hypothesis that Ca2+/calmodulin-dependent protein kinase II (CaMK II), which is activated by elevated [Ca2+](i), increases c-fos transcription and DNA synthesis via a Src-based mechanism. In cultured rat mesangial cells, dominant negative Src (SrcK-) blocked activation of the c-fos gene promoter by CaMK II 290, a constitutively active form of CaMK IIalpha. Activation of the c-fos promoter by CaMK 11290 was also blocked by COOH-terminal Src kinase, which phosphorylates and inactivates c-Src. A pharmacologic CaMK inhibitor, KN-93, did not block activation of the c-fos promoter by ectopically expressed v-Src. Stimulation of c-Src by endothelin-1 required CaMK II activity, further supporting the notion that CaMK II acts upstream of Src in a signaling cassette. Activation of the c-fos promoter by CaMKII290 and Src required the c-fos serum response element. Dominant negative SrcK- also blocked induction of DNA synthesis in mesangial cells by CaMK II290. Collectively, these results suggest that in mesangial cells Src protein tyrosine kinases act downstream of CaMKII in a signaling pathway in which [Ca2+](i) induces the c-fos promoter and increases DNA synthesis. mss5@po.cwru.edu.
引用
收藏
页码:28 / 36
页数:9
相关论文
共 34 条
[1]   MYC BUT NOT FOS RESCUE OF PDGF SIGNALING BLOCK CAUSED BY KINASE INACTIVE SRC [J].
BARONE, MV ;
COURTNEIDGE, S .
NATURE, 1995, 378 (6556) :509-512
[2]   Endothelin antagonists in renal disease [J].
Benigni, A ;
Madias, NE ;
Remuzzi, G ;
Siragy, HM ;
Brooks, DP ;
Rossi, GP ;
Abbate, M ;
Ong, A ;
Loeffler, BM ;
Bender, N ;
Noris, M ;
Ruggenenti, P ;
Wilson, C .
KIDNEY INTERNATIONAL, 2000, 57 (04) :1778-1794
[3]  
Bonventre JV, 1996, CLIN EXP PHARMACOL P, V23, P65
[4]  
Fogo AB, 1999, EXP NEPHROL, V7, P147
[5]   Ca2+ entry in CHO cells, after Ca2+ stores depletion, is mediated by arachidonic acid [J].
Gailly, P .
CELL CALCIUM, 1998, 24 (04) :293-304
[6]  
Haas CS, 1999, J NEPHROL, V12, P405
[7]   NEURONAL CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASES [J].
HANSON, PI ;
SCHULMAN, H .
ANNUAL REVIEW OF BIOCHEMISTRY, 1992, 61 :559-601
[8]   NUCLEAR SIGNALING BY ENDOTHELIN-1 - A RAS PATHWAY FOR ACTIVATION OF THE C-FOS SERUM RESPONSE ELEMENT [J].
HERMAN, WH ;
SIMONSON, MS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (19) :11654-11661
[9]   Update on endothelins - biology and clinical implications [J].
Hunley, TE ;
Kon, V .
PEDIATRIC NEPHROLOGY, 2001, 16 (09) :752-762
[10]   NOVEL HIGHLY SPECIFIC AND POTENT INHIBITOR OF CALMODULIN-DEPENDENT PROTEIN-KINASE-II [J].
ISHIDA, A ;
KAMESHITA, I ;
OKUNO, S ;
KITANI, T ;
FUJISAWA, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 212 (03) :806-812